Financial reports
10-K
2023 FY
Annual report
10 Apr 24
NT 10-K
Notice of late annual filing
1 Apr 24
10-Q
2023 Q3
Quarterly report
13 Nov 23
10-Q
2023 Q2
Quarterly report
11 Aug 23
10-Q
2023 Q1
Quarterly report
12 May 23
10-K
2022 FY
Annual report
31 Mar 23
10-Q
2022 Q3
Quarterly report
14 Nov 22
10-Q
2022 Q2
Quarterly report
12 Aug 22
10-Q
2022 Q1
Quarterly report
12 May 22
10-K
2021 FY
Annual report
31 Mar 22
Current reports
8-K
Departure of Directors or Certain Officers
6 Apr 23
8-K
Regulation FD Disclosure
14 Jun 22
8-K
Bioadaptives Acquires Oxygenated Water Technology Patent and Forms Subsidiary, MORO2, Inc., to Create New Products
3 Feb 22
8-K
Bioadaptives Signs Letter of Intent to Acquire Oxygenated Water Technology Patent
21 Jan 22
8-K
Bioadaptives – Lungflute™ Marketing Agreement and New Product
16 Dec 21
8-K
Regulation FD Disclosure
27 Aug 21
8-K
Bioadaptives - Livestock Impact Division Announcement
22 Jul 21
8-K
Entry into a Material Definitive Agreement
11 Jun 21
8-K
Equine feed supplement improves performance/appearance – Great initial reports Safe Harbor Statement
16 Jun 20
8-K
Other Events
11 May 20
Registration and prospectus
1-A
Offering $200.00 k in Debt
11 Oct 23
1-Z
Offering exit report
24 Aug 23
1-A POS
Offering $200.00 k in Equity
7 Nov 22
1-A POS
Offering $200.00 k in Equity
28 Oct 22
1-A POS
Offering $200.00 k in Equity
7 Oct 22
253G1
Information omitted from offering circular
16 May 22
1-A/A
Offering $1.5M in Equity
2 May 22
1-A/A
Offering $1.5M in Equity
18 Mar 22
1-A
Offering $1.5M in Equity
3 Mar 22
10-12G/A
Registration of securities (amended)
23 Jul 19
Other
QUALIF
Notice of qualification
18 Nov 22
CORRESP
Correspondence with SEC
15 Nov 22
UPLOAD
Letter from SEC
31 Oct 22
CORRESP
Correspondence with SEC
28 Oct 22
UPLOAD
Letter from SEC
20 Oct 22
QUALIF
Notice of qualification
12 May 22
CORRESP
Correspondence with SEC
9 May 22
UPLOAD
Letter from SEC
30 Mar 22
UPLOAD
Letter from SEC
16 Mar 22
UPLOAD
Letter from SEC
1 Aug 19